Cortical phase changes in Alzheimer's disease at 7T MRI: A novel imaging marker

Autor: Jeroen van der Grond, Mark A. van Buchem, Andrea B. Maier, Michael K. Liem, Ania M. Oleksik, Andrew G. Webb, Julien Milles, Sanneke van Rooden, Maarten J. Versluis
Přispěvatelé: Internal medicine, MOVE Research Institute, Neuromechanics, Research Institute MOVE
Rok vydání: 2013
Předmět:
Male
Postmortem studies
Pathology
medicine.medical_specialty
Epidemiology
Image Processing
Clinical Neurology
Hippocampus
Brain imaging
Human 7T MRI
Statistics
Nonparametric

Cellular and Molecular Neuroscience
Computer-Assisted
SDG 3 - Good Health and Well-being
Developmental Neuroscience
Neuroimaging
Alzheimer Disease
Cortex (anatomy)
Alzheimer Disease/pathology
80 and over
Image Processing
Computer-Assisted

medicine
Humans
Nonparametric
AD pathology
Aged
Cerebral Cortex
Aged
80 and over

medicine.diagnostic_test
Health Policy
Statistics
Phase changes
Magnetic resonance imaging
Biomarker
Alzheimer's disease
medicine.disease
Magnetic Resonance Imaging
Psychiatry and Mental health
medicine.anatomical_structure
Cerebral cortex
Biomarker (medicine)
Female
Neurology (clinical)
Geriatrics and Gerontology
Psychology
Cerebral Cortex/pathology
Zdroj: Alzheimers & Dementia, 10(1), e19-e26. Elsevier
Alzheimers & Dementia, 10(1), e19-26. Elsevier Inc.
van Rooden, S, Versluis, M J, Liem, M K, Milles, J, Maier, A B, Oleksik, A M, Webb, A G, van Buchem, M A & van der Grond, J 2014, ' Cortical phase changes in Alzheimer's disease at 7T MRI : a novel imaging marker ', Alzheimers & Dementia, vol. 10, no. 1, pp. e19-26 . https://doi.org/10.1016/j.jalz.2013.02.002
van Rooden, S, Versluis, M J, Liem, M K, Milles, J, Maier, A B, Oleksik, A M, Webb, A G, van Buchem, M A & van der Grond, J 2014, ' Cortical phase changes in Alzheimer's disease at 7T MRI: a novel imaging marker ', Alzheimers & Dementia, vol. 10, no. 1, pp. e19-e26 . https://doi.org/10.1016/j.jalz.2013.02.002
ISSN: 1552-5279
1552-5260
Popis: BACKGROUND: Postmortem studies have indicated the potential of high-field magnetic resonance imaging (MRI) to visualize amyloid depositions in the cerebral cortex. The aim of this study is to test this hypothesis in patients with Alzheimer's disease (AD).METHODS: T2*-weighted MRI was performed in 16 AD patients and 15 control subjects. All magnetic resonance images were scored qualitatively by visual assessment, and quantitatively by measuring phase shifts in the cortical gray matter and hippocampus. Statistical analysis was performed to assess differences between groups.RESULTS: Patients with AD demonstrated an increased phase shift in the cortex in the temporoparietal, frontal, and parietal regions (P < .005), and this was associated with individual Mini-Mental State Examination scores (r = -0.54, P < .05).CONCLUSION: Increased cortical phase shift in AD patients demonstrated on 7-tesla T2*-weighted MRI is a potential new biomarker for AD, which may reflect amyloid pathology in the early stages.
Databáze: OpenAIRE